InvestorsHub Logo
Followers 163
Posts 8738
Boards Moderated 1
Alias Born 04/10/2012

Re: None

Friday, 07/31/2015 1:11:57 AM

Friday, July 31, 2015 1:11:57 AM

Post# of 2
Market Announcement – Listing of Wholly Owned Subsidiary
The Directors of iQnovate Limited (NSX:IQN) (the Company) are pleased to announce that the
Board has resolved to float its wholly owned pharmaceutical contract sales subsidiary,
FarmaForce Pty Ltd (FarmaForce), via a new proposed ASX listing. The Company has
committed to an IPO of FarmaForce and listing on the ASX by the end of the 3rd quarter 2015.
Preliminary market research has indicated significant demand for this raising and it is
anticipated that the proposed offer will be oversubscribed.
The key details of this proposed new float, which is subject to all necessary approvals being
obtained, are:
• Offer to be made via a Prospectus
• Capital Raising – it is proposed to raise at least $4 million
• iQnovate Ltd shareholders will not be offered a priority entitlement under the offer as
the company intends to retain a majority shareholding in FarmaForce
• iQnovate Ltd – the Company’s shareholding in FarmaForce will be diluted by the
proportion of the offer.
The funds raised will be applied to working capital and the continued development of the
FarmaForce Pty Ltd business.
iQnovate Limited Chief Executive Officer Dr George Syrmalis said “Farmaforce is Australia’s
most innovative pharmaceutical sales organization currently engaging in deals with
multinational pharmaceutical companies. The company’s growth since inception has been
remarkable and a listing on the ASX will provide a platform for further corporate growth”.


https://www.nsxa.com.au/ftp/news/021729866.PDF

C4urself the 1st Ammendment.
Don't assume that i don't know, and i wont assume, that you have no idea.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.